Begin main content

Natriuretic Peptide testing for Monitoring of Oncology Therapy: Clinical Utility, Cost-Effectiveness, and Guidelines

Last updated: August 6, 2019
Project Number: RB1360-000
Product Line: Rapid Response
Research Type: Devices and Systems
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical utility of natriuretic peptide testing for monitoring of cardiotoxicity of oncology therapy?
  2. What is the cost-effectiveness of natriuretic peptide testing for monitoring cardiotoxicity of oncology therapy?
  3. What are the guidelines for natriuretic peptide testing for monitoring cardiotoxicity of oncology therapy?

Key Message

Nine non-randomized studies were identified regarding the clinical utility of natriuretic peptide testing for monitoring of cardiotoxicity of oncology therapy. In addition, two evidence-based guidelines were identified regarding natriuretic peptide testing for monitoring cardiotoxicity of oncology therapy. No relevant economic evaluations were identified.